Consensus Immunocore Holdings plc

Equities

IMCR

US45258D1054

Market Closed - Nasdaq Other stock markets 21:30:01 03/05/2024 BST			5-day change	1st Jan Change
60.23 ^USD	+1.29%		+3.03%	-11.84%

04-29	Leerink Partners Starts Immunocore Holdings With Outperform Rating, $74 Price Target	MT
03-21	Immunocore Holdings Files Mixed-Securities Shelf Registration	MT

Evolution of the average Target Price on Immunocore Holdings plc

Price target over the last 5 years

History of analyst recommendation changes

71ce7738c88b8c5625ad2.dG-efYmUa0_t28LT0tqYlHrH3B0XkNgD_O9cluqI7jc.KwDuJL3XWRCuuI6btamu-k-S7kxUw-pXs61k07LLukQ4AOxM0eRYFY-yhw~3f3842444c50f87f040e65e7773bfb2f

Analyst Recommendations on Immunocore Holdings plc

Leerink Partners Starts Immunocore Holdings With Outperform Rating, $74 Price Target	04-29	MT
Mizuho Securities Raises Immunocore Price Target to $90 From $86, Maintains Buy Rating	03-04	MT
Oppenheimer Adjusts Immunocore Price Target to $87 From $85, Maintains Outperform Rating	02-29	MT
Mizuho Raises Price Target on Immunocore to $86 From $72 Ahead of Q4 2023 Earnings Announcement, Reiterates Buy Rating	02-15	MT
Mizuho Cuts Price Target on Immunocore to $72 From $74, Reiterates Buy Rating	11-10	MT
Cantor Fitzgerald Initiates Coverage on Immunocore with Overweight Rating	11-02	MT
Baird Initiates Immunocore With Outperform Rating, Price Target is $84	31/10/23	MT
Oppenheimer Adjusts Immunocore Price Target to $85 From $75, Maintains Outperform Rating	21/09/23	MT
Needham Starts Immunocore Holdings at Buy With $75 Price Target	13/09/23	MT
Capital One Initiates Immunocore Holdings With Overweight Rating, $84 Price Target	16/08/23	MT
Guggenheim Adjusts Price Target on Immunocore to $92 From $87, Maintains Buy Rating	11/08/23	MT
Jefferies Raises Immunocore Holdings' Price Target to $80 From $74, Keeps Buy Rating	11/08/23	MT
Goldman Sachs Raises Immunocore Holdings' Price Target to $83 From $80, Keeps Buy Rating	11/08/23	MT
BTIG Adjusts Immunocore Holdings' Price Target to $91 From $85, Keeps Buy Rating	11/08/23	MT
Oppenheimer Adjusts Immunocore Price Target to $75 From $72, Maintains Outperform Rating	11/08/23	MT
Canaccord Genuity Initiates Coverage on Immunocore With Hold Rating, $67 Price Target	17/07/23	MT
Mizuho Raises Price Target on Immunocore Holdings to $74 From $70, Keeps Buy Rating	11/05/23	MT
Mizuho Initiates Immunocore at Buy With $70 Price Target	31/03/23	MT
Guggenheim Starts Immunocore Holdings at Buy With $85 Price Target	30/03/23	MT
Oppenheimer Adjusts Immunocore's Price Target to $72 From $65, Maintains Outperform Rating	15/02/23	MT
Goldman Sachs Upgrades Immunocore to Buy From Neutral, Raises Price Target to $80 From $33	16/12/22	MT
Barclays Initiates Immunocore Holdings With Overweight Rating, Sets $80 Price Target	30/11/22	MT
HC Wainwright Ups Price Target on Immunocore Holdings to $90 From $80, Reiterates Buy Rating	21/11/22	MT
Morgan Stanley Adjusts Price Target on Immunocore Holdings to $79 From $72, Maintains Overweight Rating	10/11/22	MT
Cowen Adjusts Immunocore Holdings Price Target to $85 From $80, Maintains Outperform Rating	09/11/22	MT

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

47.59 GBP

Average target price

66.95 GBP

Spread / Average Target

+40.68%

High Price Target

74.58 GBP

Spread / Highest target

+56.74%

Low Price Target

49.79 GBP

Spread / Lowest Target

+4.63%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Immunocore Holdings plc

Leerink Partners
Mizuho Securities
Oppenheimer
Cantor Fitzgerald
Baird
Needham & Co.
Capital One Securities
Guggenheim
Goldman Sachs
Jefferies & Co.
BTIG
Canaccord Genuity
Barclays
HC Wainwright
Morgan Stanley
Cowen
JPMorgan Chase
Ladenburg Thalmann
J.P. Morgan Chase

Ratings for Immunocore Holdings plc

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar